TIBET AIM PHARM INTIBET AIM PHARM INTIBET AIM PHARM IN

TIBET AIM PHARM IN

No trades
See on Supercharts

002826 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. Its products include miglitol tablets, gualoupi injections, nalmefene hydrochloride injections, carbetocin injections, hongjin xiaojie tablets, and aceclofenac enteric-coated tablets. The company was founded on December 29, 2007 and is headquartered in Chengdu, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
002826 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company